- Home
- Equipment
- usa massachusetts
- platelet count
Refine by
Platelet Count Equipment Supplied In Usa Massachusetts
5 equipment items found
Manufactured by:Haemonetics Corporation based inBoston, MASSACHUSETTS (USA)
Collecting more platelets starts with reaching more donors. And many donors—from smaller individuals to those with lower platelet counts or time constraints—are more suited to single unit collections. Many other potential donors only consider donation when mobile units come to them. ...
Manufactured by:Andreas Hettich GmbH & Co. KG based inTuttlingen, GERMANY
The EBA 200 is a compact clinical centrifuge offering performance and safety for small sample volumes. The EBA 200 features a built-in, versatile, 8-place, fixed-angle rotor and adjustable LCD display for convenient and quick operation. The higher performance “S” version is best for a quick turnaround of time-sensitive samples and delivers an RCF of 6,153, making it ideal for STAT, ...
Manufactured by:Andreas Hettich GmbH & Co. KG based inTuttlingen, GERMANY
The EBA 200 and EBA 200 S are practical, compact centrifuges for small sample sizes. The high speed S model can deliver reliable results in 3 minutes or less. Included an 8-place fixed angle rotor to hold standard blood and urine tubes up to 15 ml in ...
Manufactured by:Eagle Pharmaceuticals, Inc. based inWoodcliff Lake, NEW JERSEY (USA)
Indications: BELRAPZO® (bendamustine hydrochloride injection) is indicated for the treatment of patients with chronic lymphocytic leukemia (CLL). Efficacy relative to first-line therapies other than chlorambucil has not been established. BELRAPZO® (bendamustine hydrochloride injection) is indicated for the treatment of patients with indolent B-cell non-Hodgkin lymphoma (NHL) that has ...
Manufactured by:Eagle Pharmaceuticals, Inc. based inWoodcliff Lake, NEW JERSEY (USA)
Indication: PEMFEXY is indicated in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC). PEMFEXY is indicated as a single agent for the maintenance treatment of patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) whose disease has not progressed after four ...